Literature DB >> 34176725

Can we decloak how infections drive complications after lung transplantation?

Hrishikesh S Kulkarni1, Erika D Lease2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34176725      PMCID： PMC8405575          DOI： 10.1016/j.healun.2021.05.009

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   13.569


× No keyword cloud information.
  18 in total

Review 1.  Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.

Authors:  Colleen S Curran; Thomas Bolig; Parizad Torabi-Parizi
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

2.  Successful Pseudomonas aeruginosa eradication improves outcomes after lung transplantation: a retrospective cohort analysis.

Authors:  Benedicte De Muynck; Anke Van Herck; Annelore Sacreas; Tobias Heigl; Janne Kaes; Arno Vanstapel; Stijn E Verleden; Arne P Neyrinck; Laurens J Ceulemans; Dirk E Van Raemdonck; Katrien Lagrou; Bart M Vanaudenaerde; Geert M Verleden; Robin Vos
Journal:  Eur Respir J       Date:  2020-10-01       Impact factor: 16.671

3.  Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation.

Authors:  Cody A Moore; Joseph M Pilewski; Raman Venkataramanan; Keven M Robinson; Matthew R Morrell; Stephen R Wisniewski; Adriana Zeevi; John F McDyer; Christopher R Ensor
Journal:  Transpl Infect Dis       Date:  2017-04-17       Impact factor: 2.228

4.  Host-Pathogen Interactions and Chronic Lung Allograft Dysfunction.

Authors:  John Belperio; Scott M Palmer; S Sam Weigt
Journal:  Ann Am Thorac Soc       Date:  2017-09

Review 5.  Complement system in lung transplantation.

Authors:  Hakim Azfar Ali; Elizabeth N Pavlisko; Laurie D Snyder; Michael Frank; Scott M Palmer
Journal:  Clin Transplant       Date:  2018-02-14       Impact factor: 2.863

6.  Treatment of life-threatening Pseudomonas aeruginosa infection by pheresis of inhibitory antibodies.

Authors:  Chandima Divithotawela; Amy Pham; Emma L Ledger; Peter Hopkins; Timothy J Wells; Daniel Chambers
Journal:  J Heart Lung Transplant       Date:  2019-10-21       Impact factor: 10.247

7.  Cystic Fibrosis Lung Transplant Recipients Have Suppressed Airway Interferon Responses during Pseudomonas Infection.

Authors:  Daniel T Dugger; Monica Fung; Lorna Zlock; Saharai Caldera; Louis Sharp; Steven R Hays; Jonathan P Singer; Lorriana E Leard; Jefferey A Golden; Rupal J Shah; Jasleen Kukreja; Erin Gordon; Walter Finkbeiner; Mary Ellen Kleinhenz; Chaz Langelier; John R Greenland
Journal:  Cell Rep Med       Date:  2020-07-21

8.  Pseudomonas aeruginosa Induced Airway Epithelial Injury Drives Fibroblast Activation: A Mechanism in Chronic Lung Allograft Dysfunction.

Authors:  L A Borthwick; M I Suwara; S C Carnell; N J Green; R Mahida; D Dixon; C S Gillespie; T N Cartwright; J Horabin; A Walker; E Olin; M Rangar; A Gardner; J Mann; P A Corris; D A Mann; A J Fisher
Journal:  Am J Transplant       Date:  2016-02-26       Impact factor: 8.086

9.  Inferior outcomes in lung transplant recipients with serum Pseudomonas aeruginosa specific cloaking antibodies.

Authors:  Chandima Divithotawela; Amy Pham; Peter T Bell; Emma L Ledger; Maxine Tan; Stephanie Yerkovich; Michelle Grant; Peter M Hopkins; Timothy J Wells; Daniel C Chambers
Journal:  J Heart Lung Transplant       Date:  2021-05-30       Impact factor: 10.247

10.  Pseudomonas aeruginosa and acute rejection independently increase the risk of donor-specific antibodies after lung transplantation.

Authors:  Hrishikesh S Kulkarni; Kevin Tsui; Suraj Sunder; Alex Ganninger; Laneshia K Tague; Chad A Witt; Derek E Byers; Elbert P Trulock; Ruben Nava; Varun Puri; Daniel Kreisel; Thalachallour Mohanakumar; Andrew E Gelman; Ramsey R Hachem
Journal:  Am J Transplant       Date:  2019-12-24       Impact factor: 8.086
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.